IOA-244
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for IOA-244, covering 2026-03-30 to 2026-03-30. Get the full timeline:
Most recent: Clinical Trial Update: A Study to Assess a PI3Kδ Inhibitor (IOA-244) in Patients With Metastatic Cancers [Phase 1]